Snap-on Gears Up for Q2 Earnings: What Lies Ahead for the Stock? — Neutral
SNA Zacks Investment Research — July 11, 2025SNA grapples with macro headwinds and cost inflation amid a slowdown in its Tools Group segment.
“Nobody Ever Went Broke Taking a Profit” – Grab The Highest-Yielding S&P 500 Stocks Right Now — Positive
AES LYB MO PFE VZ 24/7 Wall Street — July 11, 2025A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who want to keep their money are in bonds.
Levi Strauss' Q2 Earnings Beat Estimates on Solid DTC Business — Positive
LEVI Zacks Investment Research — July 11, 2025LEVI tops second-quarter fiscal 2025 estimates with rising EPS and sales, fueled by strong DTC gains and momentum in global comps.
AMC Stock Just Got Upgrade — Could Premium Screens, Box Office Momentum Signal A Comeback? — Positive
AMC Benzinga — July 11, 2025AMC Entertainment AMC stock surged on Friday after Wedbush analyst Alicia Reese upgraded it from Neutral to Outperform and raised its price forecast from $3 to $4.
CAVA is a great growth story with rapid restaurant expansion, strong same-store sales, and a robust balance sheet fueling further growth. CAVA's unique position as the leading Mediterranean chain in the U.S. gives it first-mover advantages and a significant runway for expansion. Valuation is fair after the recent dip, but I would buy on a pullback in the high 70s-low 80s range with a larger margin of safety.
Missed Palantir Stock? These 2 AI Stocks Offer Growth at a Compelling Discount — Positive
CRM IBM 24/7 Wall Street — July 11, 2025If you missed the boat on Palantir (NASDAQ:PLTR) stock's incredibly multi-bagger surge over the past year and aren't remotely interested in chasing the stock, especially as some insiders offload their shares for a huge profit, you've come to the right place.
FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill — Positive
MRK Zacks Investment Research — July 11, 2025MRK's regulatory filing for once-daily HIV pill DOR/ISL gets FDA acceptance, with a decision expected by April 2026.
Teradyne (TER) Moves 6.3% Higher: Will This Strength Last? — Positive
TER Zacks Investment Research — July 11, 2025Teradyne (TER) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Check Point Software Technologies Named a Leader in Zero Trust Platforms, Q3 2025 Evaluation — Neutral
CHKP GlobeNewsWire — July 11, 2025REDWOOD CITY, Calif., July 11, 2025 (GLOBE NEWSWIRE) -- Check Point® Software Technologies Ltd.
Unilever appoints new Ben & Jerry's CEO as battle over board's lefty politics heats up — Neutral
UL New York Post — July 11, 2025Jochanan Senf, a Dutch Unilever executive who previously managed Ben & Jerry's Europe business, will start in the new role this month.
Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
IOVA PRNewsWire — July 11, 2025LOS ANGELES , July 11, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA) have opportunity to lead the securities fraud class action lawsuit.
Global Payments Teams Up With Oro to Launch OroPay for B2B Firms — Positive
GPN Zacks Investment Research — July 11, 2025GPN launches OroPay with Oro, streamlining B2B transactions and expanding its embedded finance reach.
Is MongoDB Rapidly Becoming the Go-To Database for AI Workloads? — Positive
MDB Zacks Investment Research — July 11, 2025MDB rides AI momentum with Atlas growth, Voyage AI upgrades and tools like MCP to streamline LLM-powered development.
Tariffs Hit Brazil: Can MELI Maintain Momentum in its Biggest Market? — Negative
MELI Zacks Investment Research — July 11, 2025MercadoLibre faces pressure as U.S. tariffs on Brazil raise concerns over currency, growth, and e-commerce demand.
Will Wingstop (WING) Beat Estimates Again in Its Next Earnings Report? — Positive
WING Zacks Investment Research — July 11, 2025Wingstop (WING) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Allegheny Technologies (ATI) Could Beat Earnings Estimates Again — Positive
ATI Zacks Investment Research — July 11, 2025Allegheny Technologies (ATI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Virtu Financial (VIRT) Beat Estimates Again in Its Next Earnings Report? — Positive
VIRT Zacks Investment Research — July 11, 2025Virtu Financial (VIRT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will BWX (BWXT) Beat Estimates Again in Its Next Earnings Report? — Positive
BWXT Zacks Investment Research — July 11, 2025BWX (BWXT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? — Positive
PFE Zacks Investment Research — July 11, 2025Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
